FBInvestor
Stocks / Kairos Pharma Ltd
Institutional Ownership

Kairos Pharma Ltd

CUSIP 48301N104COMKAPAQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon